Literature DB >> 964510

Circadian variation of serum glucose, C-peptide immunoreactivity and free insulin normal and insulin-treated diabetic pregnant subjects.

S B Lewis, J D Wallin, H Kuzuya, W K Murray, D R Coustan, T A Daane, A H Rubenstein.   

Abstract

To examine differences among pregnant diabetic and nondiabetic subjects, serum glucose, and immunoreactivity of C-peptide, free and total insulin were measured at hourly intervals during a 24--h third trimester metabolic ward evaluation. Six normals, three mild, and four juvenile-onset type diabetics were studied. Diets were identical for all subjects. Mild diabetics differed from juvenile diabetics by having significant residual pancreatic B-cell function, as measured by C-peptide immunoreactivity. Short and intermediate acting insulins given once or twice daily to diabetics maintained serum glucose levels within the normal range throughout the 24 h. Despite wide variation in serum total insulin levels, peripheral free insulin concentrations in well-controlled diabetics fell within a relatively narrow range that was higher than in controls. Infants of the diabetic subjects were comparable to the offpsring of the control women.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 964510     DOI: 10.1007/BF00420978

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  20 in total

1.  Treatment of diabetic pregnancy.

Authors:  B Persson
Journal:  Isr J Med Sci       Date:  1975-06

2.  PLASMA INSULIN IN NORMAL MIDPREGNANCY.

Authors:  W N SPELLACY; F C GOETZ; B Z GREENBERG; J ELLS
Journal:  Am J Obstet Gynecol       Date:  1965-05-01       Impact factor: 8.661

3.  Human C-peptide in normal and diabetic subjects.

Authors:  L G Heding; S M Rasmussen
Journal:  Diabetologia       Date:  1975-06       Impact factor: 10.122

4.  A simple method for the determination of serum free insulin levels in insulin-treated patients.

Authors:  S Nakagawa; H Nakayama; T Sasaki; K Yoshino; Y Y Yu
Journal:  Diabetes       Date:  1973-08       Impact factor: 9.461

5.  Plasma proinsulin-like material in insulin treated diabetics.

Authors:  G Fink; J C Cresto; R A Gutman; R L Lavine; A H Rubenstein; L Recant
Journal:  Horm Metab Res       Date:  1974-11       Impact factor: 2.936

6.  Plasma immunoreactive insulin patterns in insulin-treated diabetics. Studies during continuous blood glucose monitoring.

Authors:  G D Molnar; W F Taylor; A L Langworthy
Journal:  Mayo Clin Proc       Date:  1972-10       Impact factor: 7.616

7.  Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusion.

Authors:  W G Blackard; N C Nelson
Journal:  Diabetes       Date:  1970-05       Impact factor: 9.461

8.  The outcome of diabetic pregnancies in relation to the mother's blood sugar level.

Authors:  K Karlsson; I Kjellmer
Journal:  Am J Obstet Gynecol       Date:  1972-01-15       Impact factor: 8.661

9.  Carbohydrate metabolism in pregnancy. Part I. Diurnal plasma glucose profile in normal and diabetic women.

Authors:  M D Gillmer; R W Beard; F M Brooke; N W Oakley
Journal:  Br Med J       Date:  1975-08-16

10.  Effect of glucagon on net splanchnic cyclic AMP production in normal and diabetic men.

Authors:  J E Liljenquist; J D Bomboy; S B Lewis; B C Sinclair-Smith; P W Felts; W W Lacy; O B Crofford; G W Liddle
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

View more
  8 in total

Review 1.  Glycemic targets in pregnancies affected by diabetes: historical perspective and future directions.

Authors:  Teri L Hernandez
Journal:  Curr Diab Rep       Date:  2015-01       Impact factor: 4.810

2.  Problems and practical solutions in the external quality control of point of care devices with respect to the measurement of blood glucose.

Authors:  William Graham Wood
Journal:  J Diabetes Sci Technol       Date:  2007-03

3.  Giants in Obstetrics and Gynecology: A profile of Donald R. Coustan, MD.

Authors:  Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2017-07-10       Impact factor: 8.661

Review 4.  Insulin use in pregnancy. Clinical pharmacokinetic considerations.

Authors:  G Crombach; M Siebolds; R Mies
Journal:  Clin Pharmacokinet       Date:  1993-02       Impact factor: 6.447

Review 5.  Third trimester glycemic profiles and fetal growth.

Authors:  Gustavo Leguizamón; Francisco von Stecher
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

6.  Metabolism and placental transfer of 125I-proinsulin and 125I-tyrosylated C-peptide in the pregnant rhesus monkey.

Authors:  P A Gruppuso; J B Susa; P Sehgal; B Frank; R Schwartz
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

7.  Pregnancy in Type 1 Diabetes Mellitus: How Special are Special Issues?

Authors:  Navneet Magon; Monica Chauhan
Journal:  N Am J Med Sci       Date:  2012-06

Review 8.  Patterns of glycemia in normal pregnancy: should the current therapeutic targets be challenged?

Authors:  Teri L Hernandez; Jacob E Friedman; Rachael E Van Pelt; Linda A Barbour
Journal:  Diabetes Care       Date:  2011-07       Impact factor: 19.112

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.